Literature DB >> 32287477

Membrane Glycoproteins of Enveloped Viruses.

Richard W Compans1, Maurice C Kemp1.   

Abstract

This chapter focuses on the recent information of the glycoprotein components of enveloped viruses and points out specific findings on viral envelopes. Although enveloped viruses of different major groups vary in size and shape, as well as in the molecular weight of their structural polypeptides, there are general similarities in the types of polypeptide components present in virions. The types of structural components found in viral membranes are summarized briefly in the chapter. All the enveloped viruses studied to date possess one or more glycoprotein species and lipid as a major structural component. The presence of carbohydrate covalently linked to proteins is demonstrated by the incorporation of a radioactive precursor, such as glucosamine or fucose, into viral polypeptides, which is resolved by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis. Enveloped viruses share many common features in the organization of their structural components, as indicated by several approaches, including electron microscopy, surface-labeling, and proteolytic digestion experiments, and the isolation of subviral components. The chapter summarizes the detailed structure of the glycoproteins of four virus groups: (1) influenza virus glycoproteins, (2) rhabdovirus G protein, (3) togavirus glycoprotein, and (4) paramyxovirus glycoproteins The information obtained includes the size and shape of viral glycoproteins, the number of polypeptide chains in the complete glycoprotein structure, and compositional data on the polypeptide and oligosaccharide portions of the molecules. © 1978 Academic Press Inc.

Entities:  

Year:  2008        PMID: 32287477      PMCID: PMC7146817          DOI: 10.1016/S0070-2161(08)60750-9

Source DB:  PubMed          Journal:  Curr Top Membr Transp        ISSN: 0070-2161


  160 in total

1.  ANALYSIS OF THE DEFECTIVENESS OF ROUS SARCOMA VIRUS. 3. DETERMINING INFLUENCE OF A NEW HELPER VIRUS ON THE HOST RANGE AND SUSCEPTIBILITY TO INTERFERENCE OF RSV.

Authors:  H HANAFUSA
Journal:  Virology       Date:  1965-02       Impact factor: 3.616

2.  Carbohydrates of influenza virus. I. Glycopeptides derived from viral glycoproteins after labeling with radioactive sugars.

Authors:  R T Schwarz; M F Schmidt; U Anwer; H D Klenk
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

Review 3.  Viral envelopes and their relationship to cellular membranes.

Authors:  H D Klenk
Journal:  Curr Top Microbiol Immunol       Date:  1974       Impact factor: 4.291

4.  Structure of the ribonucleoprotein of influenza virus.

Authors:  R W Compans; J Content; P H Duesberg
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

5.  Vaccinia as a model for membrane biogenesis.

Authors:  S Dales; E H Mosbach
Journal:  Virology       Date:  1968-08       Impact factor: 3.616

6.  Studies on the inhibitory effect of lectins on myxo-virus release.

Authors:  L Stitz; M Reinacher; H Becht
Journal:  J Gen Virol       Date:  1977-03       Impact factor: 3.891

7.  Antibody-induced capping of measles virus antigens on plasma membrane studied by electron microscopy.

Authors:  P W Lampert; B S Joseph; M B Oldstone
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

8.  Antigenic characterization of two sindbis envelope glycoproteins separated by isoelectric focusing.

Authors:  J M Dalrymple; S Schlesinger; P K Russell
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

9.  Crystalline antigen from the influenza virus envelope.

Authors:  C M Brand; J J Skehel
Journal:  Nat New Biol       Date:  1972-08-02

10.  Tunicamycin inhibits glycosylation and multiplication of Sindbis and vesicular stomatitis viruses.

Authors:  R Leavitt; S Schlesinger; S Kornfeld
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

View more
  1 in total

Review 1.  Antibody-mediated destruction of virus-infected cells.

Authors:  J G Sissons; M B Oldstone
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.